Posts by Admin BioAlps

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad to announce the award of a non-dilutive EUR 2.4 M grant by the Enhanced European Innovation Council (EIC) within the framework of the competitive EU Horizon 2020 Research and Innovation Program under grant agreement No…

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Bryan Gosparini, CEO at SwissKH. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Nicolas Collin, Executive Director at the Vaccine Formulation Institute. Our series aims to provide a platform for the different life sciences actors from western…

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Guido Kohler, CEO at AquaNetto. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article is part of BioAlps’ testimonial series and was written by Mr Nicolas Tièche, Head of Bulle Site at UCB. Our series aims to provide a platform for the different life sciences actors from western Switzerland,…

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is part of BioAlps’ testimonial series and was written by Dr Sebastien Mosser, Chief Operating Officer at Neurix SA. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who…

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Prof. Gerrit Borchard, Biopharmaceuticals, Group Leader, CRTOH associate member, School of Pharmaceutical Sciences, University of Geneva. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who…

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series and was written by Mr Loïc Sottas, Switzerland Country Manager at Spentys. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing…

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The following article is part of BioAlps’ testimonial series and was written by Mr Fabrizio Maspero, Business Development Manager at Norgren, FAS. Our series aims to provide a platform for the different life sciences actors from…

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by Dr Samareh Azeredo da Silveira Lajaunias, Co-Founder & General Manager at Combioxin SA. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and…